Technology | June 17, 2011

FDA Clears New Endologix Low-Profile Stent Graft

June 17, 2011 — Endologix Inc. received U.S. Food and Drug Administration (FDA) approval for AFX Endovascular AAA System for the treatment of abdominal aortic aneurysms (AAA). The company is introducing AFX at the annual meeting of the Society for Vascular Surgery (SVS),  June 16-18, 2011 in Chicago.

AFX builds upon previous anatomical fixation technology with a new low-profile, highly precise delivery system and a state-of-the-art, proprietary stent graft material (STRATA). The key features of the AFX System include:

• Low-profile 17 French introducer sheath – The entire family of AFX stent grafts, which range in diameter from 13 to 34 millimeters, are delivered through a low profile, hydrophilically coated 17 French introducer sheath – eliminating the need for exchanges. This sheath technology, combined with the system's percutaneous (9 French) contralateral access, makes AFX the lowest-profile device approved in the U.S. for the treatment of the most common AAAs – those with aortic neck diameters of 22 millimeters or larger.

• Precise delivery and deployment – The AFX delivery system features an ergonomic dial mechanism that provides physicians with precise, controlled stent graft positioning and deployment.

• STRATA expanded polytetrafluoroethylene (ePTFE) graft – AFX stent grafts are constructed using the new STRATA graft material. STRATA is a durable, highly conformable material featuring enhanced stent graft sealing technology.

In addition to AFX, the company's complete product portfolio will be highlighted at the SVS annual meeting. This includes the investigational Nellix Endovascular System and the Ventana Fenestrated Stent Graft System, both of which will be featured in symposia at SVS.

For more information: 

Related Content

First Patient Enrolled in Gore Excluder Investigational Study
News | Stent Grafts | January 08, 2018
January 8, 2018 — W. L. Gore & Associates Inc.
FDA Concerned About Increase in stent graft Endovascular Type III Leaks
News | Stent Grafts | October 09, 2017
October 9, 2017 — The U.S.
Gore Announces First-in-Human Use of Gore TAG Conformable Thoracic Stent Graft
News | Stent Grafts | July 17, 2017
W. L. Gore & Associates Inc. announced the first patient implant of the Gore TAG Conformable Thoracic Stent Graft...
News | Stent Grafts | April 06, 2017
Endologix Inc. announced that the first patients were treated in the Expanding Patient Applicability with Polymer...
Gore, Viabahn VBX Balloon Expandable Endoprosthesis, stent graft, iliac artery, FDA approval
Technology | Stent Grafts | January 31, 2017
W. L. Gore & Associates (Gore) announced that the Gore Viabahn VBX Balloon Expandable Endoprosthesis (VBX Stent...
Lombard Medical, Aorfix endovascular stent graft, Japanese regulatory approval, IntellFlex LP Delivery System
News | Stent Grafts | January 11, 2017
January 11, 2017 — Lombard Medical Inc.
stent grafts, fluid flow model, clotting risk, Journal of Vascular Surgery

An anterior view is shown of the geometries of each of the graft configurations: (A) fenestrated, (B) antegrade branched, (C) retrograde branched, and (D) manifold stent graft. Image courtesy of Taylor Suess, et al.

News | Stent Grafts | January 05, 2017
January 5, 2017 — Whether patients with mechanical heart valves and stents must take blood thinners depends on how ef
News | Stent Grafts | December 13, 2016
Lombard Medical Inc. announced that its Altura endovascular stent graft system was featured in a scientific...
News | Stent Grafts | August 19, 2016
Endologix Inc. announced the first two patients with abdominal aortic aneurysms (AAA) have been treated with the...
bioabsorbable vascular graft, children, feasibility study, Bakoulev Center Moscow, AATS 2016 meeting

Image courtesy of Bakoulev Scientific Center for Cardiovascular Surgery

News | Stent Grafts | May 18, 2016
Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process, enabling the...
Overlay Init